With the current lack of clarity from the fda regarding the pathway for biologic generics, I would agree with you about the long if not indeterminate timeline for mnta wrt to its pipeline. I don't think they will run out of money though. The current price looks attractive to me . I will be thinking about building back a small stake between 5 and 10K.
Market Data 
Markets 
AI
